awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36952218-93EF56F4-7C7A-4EB2-8116-CF74F112F36E
Q36952218-93EF56F4-7C7A-4EB2-8116-CF74F112F36E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36952218-93EF56F4-7C7A-4EB2-8116-CF74F112F36E
Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.
P2860
Q36952218-93EF56F4-7C7A-4EB2-8116-CF74F112F36E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36952218-93EF56F4-7C7A-4EB2-8116-CF74F112F36E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ce5875e765df24ecf8248e3ded8fc696d1a43e2
P2860
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial.